Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.

Elisabeth MaillartEve TodescoLambert AssoumouYsoline BeigneuxCatherine LubetzkiCaroline PapeixRaphael De PazAnne-Laure DubessySiham DjebaraCéline LouapreValérie Pourcher

Published in: Journal of neurology (2024)

Keyphrases

end stage renal disease
newly diagnosed
immune response
chronic kidney disease
hepatitis b virus
mass spectrometry
prognostic factors
ms ms
mesenchymal stem cells
cell therapy
smoking cessation
nk cells